Free Trial
ETR:AFX

Carl Zeiss Meditec (AFX) Stock Price, News & Analysis

€64.40
-1.20 (-1.83%)
(As of 07/15/2024 ET)
Today's Range
€64.25
€65.60
50-Day Range
€63.70
€100.00
52-Week Range
€72.60
€123.75
Volume
74,947 shs
Average Volume
94,405 shs
Market Capitalization
$5.76 billion
P/E Ratio
21.98
Dividend Yield
1.71%
Price Target
N/A
AFX stock logo

About Carl Zeiss Meditec Stock (ETR:AFX)

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics (perimeters), as well as digital products for storage, evaluation, and sharing of clinical data. In addition, this segment offers surgical ophthalmology products comprising surgical microscopes, biometers, phacoemulsification, and vitrectomy devices; intraocular lenses for cataract patients; and systems and consumables for laser eye surgery. The Microsurgery segment provides products and solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, neuro, dental, and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.

AFX Stock Price History

AFX Stock News Headlines

The attacks will come for me after releasing this…
In my new exposé, I pull back the curtain on what’s really going on in America, what’s coming next, and what you must do to protect your assets before it’s too late.
Carl Zeiss Meditec AG (AFX.MU)
Carl Zeiss Meditec AG (AFX.HA)
The attacks will come for me after releasing this…
In my new exposé, I pull back the curtain on what’s really going on in America, what’s coming next, and what you must do to protect your assets before it’s too late.
Carl Zeiss Meditec AG
Carl Zeiss Meditec AG (AFX.DE)
Carl Zeiss Meditec AG (AFX.SW)
Carl Zeiss Meditec AG ADR (CZMWY)
Carl Zeiss Meditec AG AFX
See More Headlines
Receive AFX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Carl Zeiss Meditec and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Instruments & Supplies
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
4,950
Year Founded
N/A

Profitability

Net Income
$261.22 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$2.06 billion
Cash Flow
€0.05 per share
Book Value
€23.42 per share

Miscellaneous

Free Float
N/A
Market Cap
$5.76 billion
Optionable
Not Optionable
Beta
0.93
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Dr. Markus Weber
    CEO & Chairman of Management Board
  • Mr. Justus Felix Wehmer (Age 59)
    CFO & Member of the Management Board
    Comp: $609.4k
  • Dr. Christian Munster (Age 53)
    Head of Global Regulatory & Clinical Affairs, CoCe Site Jena & Emp. Rep. Member of Supervisory Board
  • Stefanie Spanagel
    Chief Operating Officer
  • Mr. Sebastian Frericks
    Director of Investor Relations
  • Eva-Maria Heine
    Chief Human Resources Officer
  • Mr. Steven C. Schallhorn M.D.
    Chief Medical Officer for Global Ophthalmic Devices
  • Mr. Andrew Chang
    Head of Sales for Ophthalmic Devices & President of Carl Zeiss Meditec, Inc.
  • Dr. Euan S. Thomson Ph.D. (Age 61)
    President of Ophthalmic Devices and Head of the Ophthalmic Devices Strategic & Digital Business Unit
  • Mr. Magnus Reibenspiess
    Head of the Microsurgery Strategic Business Unit - ZEISS Medical Technology

AFX Stock Analysis - Frequently Asked Questions

How have AFX shares performed this year?

Carl Zeiss Meditec's stock was trading at €98.84 at the start of the year. Since then, AFX stock has decreased by 34.8% and is now trading at €64.40.
View the best growth stocks for 2024 here
.

What other stocks do shareholders of Carl Zeiss Meditec own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Carl Zeiss Meditec investors own include Covestro (1COV), AbbVie (ABBV), Allianz (ALV), Daimler (DAI), Gilead Sciences (GILD) and Intel (INTC).

This page (ETR:AFX) was last updated on 7/15/2024 by MarketBeat.com Staff

From Our Partners